Literature DB >> 27029705

Activity of immune checkpoint inhibition in platinum refractory germ-cell tumors.

S Zschäbitz1, F Lasitschka2, D Jäger1, C Grüllich3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27029705     DOI: 10.1093/annonc/mdw146

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  9 in total

1.  The immunotherapy revolution in genitourinary malignancies.

Authors:  Shruti U Gandhy; Ravi A Madan; Jeanny B Aragon-Ching
Journal:  Immunotherapy       Date:  2020-06-29       Impact factor: 4.196

2.  Therapy: Anti-PD-1 antibodies: effective in GCTs?

Authors:  Rebecca Kelsey
Journal:  Nat Rev Urol       Date:  2016-04-19       Impact factor: 14.432

3.  Immune-related genes play an important role in the prognosis of patients with testicular germ cell tumor.

Authors:  Chengjian Ji; Yichun Wang; Yi Wang; Jiaochen Luan; Liangyu Yao; Yamin Wang; Ninghong Song
Journal:  Ann Transl Med       Date:  2020-07

4.  Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors.

Authors:  Michal Chovanec; Zuzana Cierna; Viera Miskovska; Katarina Machalekova; Daniela Svetlovska; Katarina Kalavska; Katarina Rejlekova; Stanislav Spanik; Karol Kajo; Pavel Babal; Jozef Mardiak; Michal Mego
Journal:  Oncotarget       Date:  2017-03-28

5.  Emerging Prognostic Biomarkers in Testicular Germ Cell Tumors: Looking Beyond Established Practice.

Authors:  Michal Chovanec; Costantine Albany; Michal Mego; Rodolfo Montironi; Alessia Cimadamore; Liang Cheng
Journal:  Front Oncol       Date:  2018-11-28       Impact factor: 6.244

6.  Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo-refractory germ cell tumors.

Authors:  Takashi Kawahara; Koji Kawai; Takahiro Kojima; Yoshiyuki Nagumo; Shotarou Sakka; Shuya Kandori; Hiromitsu Negoro; Bryan J Mathis; Kazushi Maruo; Koji Miura; Noriaki Sakamoto; Nobuo Shinohara; Shinichi Yamashita; Kan Yonemori; Takeshi Kishida; Osamu Ukimura; Kazuo Nishimura; Yasuyuki Kobayashi; Hiroyuki Nishiyama
Journal:  Int J Urol       Date:  2022-04-23       Impact factor: 2.896

7.  Systemic immune-inflammation index in germ-cell tumours.

Authors:  Michal Chovanec; Zuzana Cierna; Viera Miskovska; Katarina Machalekova; Katarina Kalavska; Katarina Rejlekova; Daniela Svetlovska; Dusan Macak; Stanislav Spanik; Karol Kajo; Pavel Babal; Ugo De Giorgi; Michal Mego; Jozef Mardiak
Journal:  Br J Cancer       Date:  2018-02-27       Impact factor: 7.640

Review 8.  Immune-Related Concepts in Biology and Treatment of Germ-Cell Tumors.

Authors:  Michal Chovanec; Ugo De Giorgi; Michal Mego
Journal:  Adv Urol       Date:  2018-03-13

9.  EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults.

Authors:  Didier Frappaz; Girish Dhall; Matthew J Murray; Stuart Goldman; Cecile Faure Conter; Jeffrey Allen; Rolf Dieter Kortmann; Daphne Haas-Kogen; Giovanni Morana; Jonathan Finlay; James C Nicholson; Ute Bartels; Mark Souweidane; Stefan Schönberger; Alexandre Vasiljevic; Patricia Robertson; Assunta Albanese; Claire Alapetite; Thomas Czech; Chin C Lau; Patrick Wen; David Schiff; Dennis Shaw; Gabriele Calaminus; Eric Bouffet
Journal:  Neuro Oncol       Date:  2022-04-01       Impact factor: 13.029

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.